Veradermics, Incorporated Common Stock (MANE)
R&D Expenses
$18.61M
Quarterly · Period ending: · USD
MANE R&D Expenses
Latest reported$18.61Mperiod ending
Latest reported$18.61Mperiod ending
MANE Quarterly R&D Expenses ($4.95M → $18.61M)
Quarterly R&D Expenses
High-resolution chart · PNG
MANE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 18,607,000 | |
| 20,925,000 | |
| 18,192,000 | |
| 18,097,000 | |
| 14,329,000 | |
| 11,447,000 | |
| 4,950,000 |